STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Oscar Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

OSCR filed a Form 144 notice for a proposed sale of common stock. The filing lists 105,300 shares to be sold with an aggregate market value of $1,585,133.55, through Morgan Stanley Smith Barney LLC, on or about 11/12/2025. The shares trade on the NYSE.

The securities to be sold were acquired on 11/12/2025 via an exercise of options under a registered plan, with payment in cash. Shares outstanding were 229,010,000 as of the figures provided. The filing also reports sales in the past three months by a named seller: 286,182 shares on 11/11/2025 for $4,369,512.63, and 395,000 shares on 09/22/2025 for $7,280,995.50.

Form 144 is a notice of proposed sale under Rule 144 and does not itself effect a sale; it discloses intent and relevant limits and timing.

Positive
  • None.
Negative
  • None.

Insights

Routine Rule 144 notice for insider share sales; informational, not a deal.

This filing states an intent to sell 105,300 OSCR common shares with an aggregate value of $1,585,133.55, acquired via option exercise under a registered plan. Rule 144 requires this notice when affiliates plan public resales, outlining the amount, timing, and broker.

Rule 144 volume and manner-of-sale conditions apply, and the filing aggregates recent sales for compliance. The table lists additional sales of 286,182 shares on 11/11/2025 and 395,000 shares on 09/22/2025. Actual sales, pricing, and timing depend on market conditions and broker execution as permitted by the rule.

This is typically neutral for valuation. It signals potential secondary selling activity; impact depends on execution and overall trading liquidity.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the OSCR Form 144 filing disclose?

It notices a proposed sale of 105,300 OSCR common shares with an aggregate market value of $1,585,133.55, to be executed through Morgan Stanley Smith Barney LLC.

When is the proposed sale of OSCR shares expected?

The approximate date of sale listed is 11/12/2025.

How were the OSCR shares to be sold acquired?

They were acquired on 11/12/2025 via an exercise of options under a registered plan, with cash payment.

How many OSCR shares are outstanding according to the filing?

Shares outstanding are listed as 229,010,000.

Were there recent OSCR share sales reported in the filing?

Yes. It reports 286,182 shares sold on 11/11/2025 for $4,369,512.63 and 395,000 shares sold on 09/22/2025 for $7,280,995.50.

Which exchange and broker are listed for the OSCR sale?

The shares trade on the NYSE, and the broker listed is Morgan Stanley Smith Barney LLC.
Oscar Health Inc

NYSE:OSCR

OSCR Rankings

OSCR Latest News

OSCR Latest SEC Filings

OSCR Stock Data

4.02B
218.66M
4.03%
76.77%
19.19%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
NEW YORK